title: [Studies on baicalin ethylcellulose microspheres for intranasal administration].
abstract: In this study, solvent evaporation method was used to preparing baicalin ethylcellulose microspheres for intranasal administration. The prepared microspheres were round with certain rough surface. The average drug loading and entrapment efficiency was (33. 31 ± 0. 045)% , (63. 34 ± 0. 11)% , respectively. As the characteristic crystalline peaks of baicalin were observed in the microspheres sample, the result of X-ray diffractometric analysis indicated that the baicalin was present in crystalline form after its entrapment in ethylcellulose matrix. By investigating the thermogram of microspheres sample, it was found that endothermic peak of baicalin was shifted from 211. 8 °C to 244. 2 °C and associated with the first broad endothermic peak of ethylcellulose. This could confirm that baicalin was loaded into ethylcellulose, nor simply physical mixture. The powder flowability test exhibited that the specific energy of microspheres was 3. 57 mJ . g-1 and the pressure drop was 2. 22 mBar when air kept the speed of 2 mm . s-1 through the powder bed with the force was 15 kPa. The consequence of the baicalin in vitro released from microspheres showed that the pure baicalin sample displayed faster (90%) release than microspheres sample (75%) in 7 h. Fitting model for release curve before 7 h, the results showed that the pure baicalin sample and the microsphere sample accorded with first order model (R2 = 0. 990 4) and Riger-Peppas model(R2 = 0. 961 2), respectively. Ex vivo rabbit nasal mucosa permeability experiment revealed that the value of cumulative release rate per unit area of the microsphere sample was 1. 56 times that of the pure baicalin sample. This provided the foundation for the in vivo pharmacokinetic study.
authors.forename: Yu-yi
authors.initials: YY
authors.lastname: Qian
authors.forename: Liu-hong
authors.initials: LH
authors.lastname: Zhang
authors.forename: Li-wei
authors.initials: LW
authors.lastname: Guo
authors.forename: Hua-xu
authors.initials: HX
authors.lastname: Zhu
authors.forename: Ting-ming
authors.initials: TM
authors.lastname: Fu
mesh_terms: D000281:Administration, Intranasal; D000399:Air Pressure; D000818:Animals; D002482:Cellulose / Q000031:analogs & derivatives* / Q000737:chemistry; D004339:Drug Compounding / Q000379:methods*; D005419:Flavonoids / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D008297:Male; D008863:Microspheres; D009092:Mucous Membrane / Q000378:metabolism; D010316:Particle Size; D011208:Powders; D011817:Rabbits; D012997:Solvents; D014961:X-Ray Diffraction
chemical_list: D005419:Flavonoids; D011208:Powders; D012997:Solvents; C038044:baicalin; C013517:ethyl cellulose; D002482:Cellulose